EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of Entamoeba fatty acid elongases; validation as targets and provision of promising leads for new drugs against amebiasis

Fumika Mi-Ichi iD, Hiroshi Tsugawa, Tam Kha Vo, Yuto Kurizaki, Hiroki Yoshida, Makoto Arita iD

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Fumika Mi-Ichi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan. Hauptthemen laut MEDLINE: Fatty Acid Elongases, Entamoeba histolytica. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Japan Program for Infectious Diseases Research and Infrastructure, “Arita Lipidome Atlas Project”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Entamoeba histolytica is a protozoan parasite belonging to the phylum Amoebozoa that causes amebiasis, a global public health problem. E . histolytica alternates its form between a proliferative trophozoite and a dormant cyst. Trophozoite proliferation is closely associated with amebiasis symptoms and pathogenesis whereas cysts transmit the disease. Drugs are available for clinical use; however, they have issues of adverse effects and dual targeting of disease symptoms and transmission remains to be improved. Development of new drugs is therefore urgently needed. An untargeted lipidomics analysis recently revealed structural uniqueness of the Entamoeba lipidome at different stages of the parasite’s life cycle involving very long (26–30 carbons) and/or medium (8–12 carbons) acyl chains linked to glycerophospholipids and sphingolipids. Here, we investigated the physiology of this unique acyl chain diversity in Entamoeba , a non-photosynthetic protist. We characterized E . histolytica fatty acid elongases (EhFAEs), which are typically components of the fatty acid elongation cycle of photosynthetic protists and plants. An approach combining genetics and lipidomics revealed that EhFAEs are involved in the production of medium and very long acyl chains in E . histolytica . This approach also showed that the K3 group herbicides, flufenacet, cafenstrole, and fenoxasulfone, inhibited the production of very long acyl chains, thereby impairing Entamoeba trophozoite proliferation and cyst formation. Importantly, none of these three compounds showed toxicity to a human cell line; therefore, EhFAEs are reasonable targets for developing new anti-amebiasis drugs and these compounds are promising leads for such drugs. Interestingly, in the Amoebazoan lineage, gain and loss of the genes encoding two different types of fatty acid elongase have occurred during evolution, which may be relevant to parasite adaptation. Acyl chain diversity in lipids is therefore a unique and indispensable feature for parasitic adaptation of Entamoeba .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acid ElongasesEntamoeba histolyticaHumansProtozoan ProteinsEntamoebaAmebiasisEntamoebiasisTrophozoitesAntiprotozoal AgentsFatty Acids

Substanzen

Fatty Acid ElongasesProtozoan ProteinsAntiprotozoal AgentsFatty Acids

Autor:innen und Institutionen

  • Central Laboratory, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
  • Division of Molecular and Cellular Immunoscience, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga, Japan.
  • Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Tokyo, Japan.
  • Laboratory for Metabolomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.
  • Division of Physiological Chemistry and Metabolism, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.

ORCID-Profile: Fumika Mi-Ichi, Makoto Arita

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan
  • Japan Program for Infectious Diseases Research and Infrastructure
  • “Arita Lipidome Atlas Project”
  • AMED Moonshot Research and Development Program
  • Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan
  • AMED Japan Program for Infectious Diseases Research and Infrastructure
  • JST ERATO “Arita Lipidome Atlas Project”
  • Moonshot Research and Development Program

Zitieren

APA

Mi-Ichi, F., Tsugawa, H., Vo, T. K., Kurizaki, Y., Yoshida, H., & Arita, M. (2024). Characterization of Entamoeba fatty acid elongases; validation as targets and provision of promising leads for new drugs against amebiasis. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012435

Vancouver

Mi-Ichi F, Tsugawa H, Vo TK, Kurizaki Y, Yoshida H, Arita M. Characterization of Entamoeba fatty acid elongases; validation as targets and provision of promising leads for new drugs against amebiasis. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012435

BibTeX
@article{MiIchi2024,
  author = {Mi-Ichi, Fumika and Tsugawa, Hiroshi and Vo, Tam Kha and Kurizaki, Yuto and Yoshida, Hiroki and Arita, Makoto},
  title = {Characterization of Entamoeba fatty acid elongases; validation as targets and provision of promising leads for new drugs against amebiasis},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012435}
}
Kostenlos starten →